Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03385798
What this trial is testing

Endo-GIA Versus Endowrist Stapler in Intracorporeal Urinary Diversion in Robotic Assisted Radical Cystectomy

Who this might be right for
Bladder Cancer
Jørgen Bjerggaard Jensen 90
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Not applicableStudy completedNCT05937555
What this trial is testing

Professional Bladder Cancers and the Profession of Painter

Who this might be right for
Bladder Cancer
University Hospital, Brest 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04482309
What this trial is testing

T-DXd in Patients With Selected HER2 Expressing Tumors

Who this might be right for
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca 477
Large-scale testing (Phase 3)Active Not RecruitingNCT06211764
What this trial is testing

TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 272
Not applicableStudy completedNCT05278598
What this trial is testing

3 Ultrasound Guided Plane Blocks for Perioperative Analgesia in Patients Undergoing Radical Cystectomy

Who this might be right for
Cancer, BladderSurgeryAnesthesia+2 more
Nazmy Edward Seif 120
Not applicableNot Yet RecruitingNCT05325216
What this trial is testing

Urinary Continence of Female POPRC and OIN

Who this might be right for
Urinary Bladder NeoplasmsWomanSexual Dysfunction, Physiological+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05024734
What this trial is testing

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

Who this might be right for
Bladder CancerNon-muscle Invasive
Roland Seiler-Blarer 31
Early research (Phase 1)WithdrawnNCT05655598
What this trial is testing

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Who this might be right for
Advanced Breast CancerTreatment-Refractory Solid TumorsRetinoblastoma Deficiency+4 more
Brown University
Not applicableStudy completedNCT05182853
What this trial is testing

Voiding Disorders in Children After Sacrococcygeal Teratoma Resection

Who this might be right for
Sacrococcygeal TeratomaNeurogenic BladderVoiding Disorders
University Hospital, Montpellier 8
Not applicableLooking for participantsNCT05415631
What this trial is testing

Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence

Who this might be right for
Bladder CancerCystoscopyArtificial Intelligence
Centre Hospitalier Universitaire, Amiens 500
Post-approval studies (Phase 4)UnknownNCT05580354
What this trial is testing

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Ruijin Hospital 42
Early research (Phase 1)Study completedNCT04601766
What this trial is testing

A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets

Who this might be right for
Bladder Cancer
Asieris Pharmaceuticals (AUS) Pty Ltd. 12
Not applicableActive Not RecruitingNCT05981131
What this trial is testing

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non Muscle Invasive Bladder Cancer
ImmunityBio, Inc. 6
Not applicableLooking for participantsNCT03193970
What this trial is testing

Measuring Surgical Recovery After Radical Cystectomy

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 2,000
Not applicableUnknownNCT03499782
What this trial is testing

Precise Treatment System of Biliary Malignancies Based on Special Disease Database

Who this might be right for
CholangiocarcinomaGall Bladder CarcinomaBiliary System Disorder
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT06637423
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 32
Not applicableStudy completedNCT04838873
What this trial is testing

Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center

Who this might be right for
Bladder CancerLaparoscopy
Cairo University 60
Testing effectiveness (Phase 2)Ended earlyNCT01215266
What this trial is testing

Sorafenib in Urothelium Cancer of Bladder

Who this might be right for
Bladder Cancer
Association of Urologic Oncology (AUO) 98
Testing effectiveness (Phase 2)Study completedNCT04525131
What this trial is testing

Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors

Who this might be right for
Bladder Cancer
CicloMed LLC 12
Next Page